StockNews.AI
SMLR
StockNews.AI
29 days

Semler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

1. Semler Scientific plans to report Q2 2025 results on August 4, 2025. 2. CEO Doug Murphy-Chutorian will host a live video webinar. 3. SMLR is the second U.S. public company adopting Bitcoin as a reserve asset. 4. Semler focuses on medical devices for chronic disease detection. 5. QuantaFlo aids in diagnosing peripheral arterial disease with FDA clearance.

5m saved
Insight
Article

FAQ

Why Bullish?

Adoption of Bitcoin as a reserve asset may enhance investor confidence. Companies integrating cryptocurrencies tend to attract interest, similar to Tesla's Bitcoin investment.

How important is it?

The integration of Bitcoin by a healthcare device company presents innovative opportunities, greatly affecting SMLR's position. Positive financial results in upcoming quarters may further validate this strategy.

Why Long Term?

Strategic Bitcoin accumulation may yield long-term financial stability and growth. Historical shifts in corporate treasury strategies often deliver sustained market performance.

Related Companies

TSLACOINMARA
, /PRNewswire/ --Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced it will report financial results for the second quarter ended June 30, 2025, after the close of U.S. financial markets on Monday, August 4, 2025. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a live video webinar at 4:30 pm ET the same day. Eric Semler, executive chairman, Renae Cormier, chief financial officer, and Joe Burnett, director of Bitcoin strategy, will join him on the call. Please submit questions prior to the start of the call to [email protected]. A live video webinar of the event can be accessed at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=GSe0xNiE. The live video webinar will also be live streamed on The Bitcoin for Corporations YouTube page at https://www.youtube.com/@BitcoinforCorporations. Those without internet access may dial in by calling one of the following numbers and specify to the operator that you would like to join the "Semler Scientific Call":Domestic callers: 833-816-1161International callers: 412-317-0717 The video webinar will be archived on Semler Scientific's website at www.semlerscientific.com. About Semler Scientific, Inc.: Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases.  By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc., develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. Additional information about Semler Scientific can be found at www.semlerscientific.com. INVESTOR CONTACT: Renae CormierChief Financial Officer[email protected] SOURCE Semler Scientific, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News